Please login to the form below

Not currently logged in

Excellence in Patient Education and Support

Sponsored by

Back to Results


Life after Heart Attack (LAHA)

By: AstraZeneca
With support from: Atlantis Healthcare

Summary of work

Acute coronary syndrome (ACS) is a set of life-threatening heart conditions including heart attack and unstable angina for which patients take a range of medications. Treatment adherence is poor, even though the consequences of non-adherence can lead to increased risk of heart attack and mortality. In Abu Dhabi, non-adherence is particularly prominent with persistence rates to OAP medication of just 35% after twelve months. ‘Life After Heart Attack’ (LAHA) a free, multi-channel support programme, was developed for patients with ACS in the United Arab Emirates. LAHA has positively impacted treatment persistence (99% at 3 months; 95% at 6 months and 83% at 12 months post-enrolment), patient beliefs and lifestyle changes.

Judges' comments

We liked the visualisation of the results within this well-executed initiative. It had demonstrable outcomes, in terms of belief, lifestyle changes and persistence, and gained excellent feedback from local cardiologists.


Patient Power - A Digital Media Channel for Patient Empowerment - By: Patient Power
With support from: Brandcast Health


Life after Heart Attack (LAHA) - By: AstraZeneca
With support from: Atlantis Healthcare

How Besins Healthcare changed IVF’s ‘Waiting Game’ - By: Besins Healthcare
With support from: VCCP Health

The Facts About Fasting During Ramadan - By: MSD
With support from: GCI Health

The Inside Story - Pompe and Fabry Disease - By: Sanofi Genzyme

Empower-ing People with Type 2 Diabetes - By: Spirit Healthcare

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022